Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Perlaza-Jimenez

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature Cell Biology|August 2, 2024
Systematic loss-of-function screens identify pathway-specific functional circular RNAsLing Liu, Matthew Neve, Laura Perlaza-Jimenez, et al.
Nature Communications|December 1, 2024
SAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identifies DNA methylation as a vulnerability in ER-positive breast cancersMahnaz Hosseinpour, Xinqi Xi, Ling Liu, et al.
NPJ Breast Cancer|January 21, 2026
CRISPR screens identify PRMT7 as a therapeutic target to enhance T cell-mediated killing in breast cancerWei Shi, Yi Luo, Yizhuo Wang, et al.
Genome Biology|March 29, 2023
CRISPR screens identify gene targets at breast cancer risk lociNatasha K Tuano, Jonathan Beesley, Murray Manning, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature Cell Biology|August 2, 2024
Systematic loss-of-function screens identify pathway-specific functional circular RNAsLing Liu, Matthew Neve, Laura Perlaza-Jimenez, et al.
Nature Communications|December 1, 2024
SAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identifies DNA methylation as a vulnerability in ER-positive breast cancersMahnaz Hosseinpour, Xinqi Xi, Ling Liu, et al.
NPJ Breast Cancer|January 21, 2026
CRISPR screens identify PRMT7 as a therapeutic target to enhance T cell-mediated killing in breast cancerWei Shi, Yi Luo, Yizhuo Wang, et al.
Genome Biology|March 29, 2023
CRISPR screens identify gene targets at breast cancer risk lociNatasha K Tuano, Jonathan Beesley, Murray Manning, et al.
Pageof 1